Rallybio Corp Files 8-K on Shareholder Vote
Ticker: RLYB · Form: 8-K · Filed: May 16, 2025 · CIK: 1739410
| Field | Detail |
|---|---|
| Company | Rallybio Corp (RLYB) |
| Form Type | 8-K |
| Filed Date | May 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: RLYB
TL;DR
Rallybio held a shareholder vote on May 13th, details to follow.
AI Summary
Rallybio Corporation filed an 8-K on May 16, 2025, reporting on a matter submitted to a vote of its security holders on May 13, 2025. The filing does not disclose the specific outcome or details of the vote, only that it occurred.
Why It Matters
This filing indicates a significant event where shareholders voted on a matter, which could impact the company's future direction or governance.
Risk Assessment
Risk Level: medium — The filing is a procedural update about a shareholder vote, but the lack of detail on the vote's subject or outcome introduces uncertainty.
Key Players & Entities
- Rallybio Corporation (company) — Registrant
- May 13, 2025 (date) — Date of earliest event reported
- May 16, 2025 (date) — Date of report
- 203-859-3820 (phone_number) — Registrant's telephone number
FAQ
What specific matter was submitted for a vote by Rallybio Corporation's security holders?
The filing does not specify the exact matter that was submitted for a vote by security holders on May 13, 2025.
What was the outcome of the shareholder vote on May 13, 2025?
The 8-K filing does not disclose the results or outcome of the shareholder vote.
When was the 8-K filing officially submitted to the SEC?
The 8-K filing was filed as of May 16, 2025.
What is Rallybio Corporation's principal executive office address?
Rallybio Corporation's principal executive offices are located at 234 Church Street, Suite 1020, New Haven, Connecticut 06510.
What is the Commission File Number for Rallybio Corporation?
Rallybio Corporation's Commission File Number is 001-40693.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 regarding Rallybio Corp (RLYB).